Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Specimen validity testing industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product & services trends
2.5 Test trends
2.6 End-use trends
Chapter 3 Specimen Validity Testing Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of illicit drug abuse
3.2.1.2 Technological advancements in specimen validity testing
3.2.1.3 Increasing demand for rapid and point of care testing
3.2.1.4 Rising awarness regarding specimen validity testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of screening tests
3.2.2.2 Development of alternate drug screening tests
3.3 Growth potential analysis
3.3.1 By product & services
3.3.2 By type
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Pricing analysis, 2022
3.8 Key market trends
3.9 Technology landscape
3.10 Future market trends
3.11 Value chain analysis
3.12 Gap Analysis
3.13 Porter's analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Vendor matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Specimen Validity Testing Market Size and Forecast, By Product & Services (USD Million)
5.1 Key trends, by product & services
5.2 Product
5.2.1 Assay Kits
5.2.2 Reagents and Calibrators
5.2.3 Disposables
5.3 Service
Chapter 6 Specimen Validity Testing Market Size and Forecast, By Type (USD Million)
6.1 Key trends, by type
6.2 Laboratory testing
6.3 Rapid/POC testing
Chapter 7 Specimen Validity Testing Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Drug screening laboratories
7.3 Drug rehabilitation centers
7.4 Pain management centers
7.5 Others
Chapter 8 Specimen Validity Testing Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Sweden
8.3.7 Poland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Philippines
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 ACM Global Laboratories.
9.3 Alfa Scientific Designs, Inc.
9.4 American Bio Medica Corporation
9.5 Danaher Corporation
9.6 Express Diagnostics
9.7 GenomeWeb LLC.
9.8 Genway Biotech, Inc.
9.9 LabCorp
9.10 Premier Biotech, Inc.
9.11 Quest Diagnostics Incorporated.
9.12 Sciteck, Inc.
9.13 SureHire
9.14 Thermo Fisher Scientific Inc.
